We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current APVO market cap is 2.16M. The company's latest EPS is USD -34.7992 and P/E is -0.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.56M | -6.38M | -6.98M | -6.02M | -5.21M |
| Net Income | -6.33M | -5.9M | -6.83M | -5.88M | -5.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.42M | 4.31M | 12.29M | 3.11M | 0 |
| Operating Income | -42.6M | -27.49M | -21.4M | -28.64M | -28.88M |
| Net Income | -40.45M | -17.75M | -28.46M | 8.03M | -17.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.13M | 24.84M | 17.63M | 14.92M | 15.15M |
| Total Liabilities | 12.41M | 12.62M | 11.53M | 10.46M | 10.73M |
| Total Equity | 14.72M | 12.22M | 6.1M | 4.46M | 4.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.41M | 53.55M | 56.6M | 34.22M | 24.84M |
| Total Liabilities | 41.57M | 36.95M | 55.39M | 16.24M | 12.62M |
| Total Equity | 11.84M | 16.59M | 1.22M | 17.97M | 12.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.48M | -11.73M | -6.65M | -12.8M | -18.03M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.95M | 6M | -3k | 3.97M | 8.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.38M | -29.32M | -21.68M | -21.02M | -11.73M |
| Investing | 4.1M | 28.03M | -713k | -29k | N/A |
| Financing | 20.15M | 23.87M | 26.16M | -2.62M | 6M |
| Market Cap | 2.16M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.13 |
| Price to Book Ratio | 0.18 |
| Dividend Yield | - |
| Shares Outstanding | 500.33k |
| Average Volume (1 week) | 60.41k |
| Average Volume (1 Month) | 63.89k |
| 52 Week Change | -98.26% |
| 52 Week High | 399.60 |
| 52 Week Low | 3.65 |
| Spread (Intraday) | 1.08 (20.97%) |
| Company Name | Aptevo Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aptevotherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
